3 Results for "

BRD4 bromodomain 1

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "BRD4 bromodomain 1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-114204
CAS No.: 1997369-78-4
Purity:  99.80%
Research Areas:  

Cancer

GSK8814 is a potent and selective ATAD2 bromodomain chemical probe and inhibitor (IC50 = 0.059 μM), with a binding constant pKd = 8.1 and a pKi = 8.9 in BROMOscan. GSK8814 binds to ATAD2 and BRD4 BD1 with pIC50s of 7.3 and 4.6, respectively. GSK8814 shows 500-fold selectivity for ATAD2 over BRD4 BD1. GSK8814 can be researched for cancer associated with ATAD2 bromodomain .
loading...
    loading...
Cat. No.: HY-W017851
CAS No.: 1198-97-6
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

4-Phenyl-2-pyrrolidinone is a precursor and synthetic intermediate. 4-Phenyl-2-pyrrolidinone can be used as a precursor in the synthesis of compounds with anticonvulsant and nootropic activities and is an intermediate in the synthesis of bromodomain-containing protein 4 (BRD4) bromodomain 1 inhibitors .
loading...
    loading...
Cat. No.: HY-182577
CAS No.: 2154350-81-7
Research Areas:  

Cancer

CFT-743, a PROTAC-based heterobifunctional degrader and BET inhibtor, is a degrader of BRD4 bromodomain 1 (BD1) with a DC50 of 4.3 nM. CFT-743's antitumor activitiy is dependent on BET degradation and can be attenuated by Pomalidomide (HY-10984), which is a CRBN binding molecule. CFT-743 induces ubiquitination of BRD4 BD1. CFT-743 can be used for cancer research .
loading...
    loading...